Wrinkle Injection With Autologous Platelet Rich Plasma Study
NCT ID: NCT01078493
Last Updated: 2016-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE1
INTERVENTIONAL
2010-02-28
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association of Photobiomodulation With Platelet Rich Plasma Intradermal Injection for Facial Rejuvenation
NCT04145999
Split Face Study of the Effects of Micro Needling With and Without Platelet Rich Plasma
NCT04219293
A Pilot Study on the Use of Platelet Rich Plasma (PRP) for Facial and Hand Skin Rejuvenation
NCT03647917
Platelet Rich Fibrin Versus Platelet Rich Plasma for Microneedling Treatment of Facial Photoaging
NCT06452667
Platelet Rich Plasma for Treatment of Facial Photoaging: A Double-blind, Randomized, Split-face Study
NCT05096650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MyCells® (injection of platelet rich plasma)
PRP contains at least 1,000,000 platelets per mm3 or 2-6 times the native concentration of whole blood at a pH of 6.5 to 6.7
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dis-satisfied or anxious about facial wrinkles (total wrinkle length more than 1cm)
Exclusion Criteria
* Psychiatric patients.
* Known bleeding disorders such as platelet dysfunction syndrome, thrombocytopenia, hypofibrinogenemia
* Anticoagulants(eg.aspirin, warfarin)
* Had other wrinkle therapy for less than a month.(laser, peels, injections)
* Had facelift surgery for less than a year.
* Diseased states such as organ failure, severe anaemia, cancer, acute/chronic infections.
* Involved in personal litigation against an aesthetic service provider
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novena Medical Center
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Life Source Medical Centre @ Novena Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kok Leong Tan, MBBS
Role: PRINCIPAL_INVESTIGATOR
Life Source Medical Centre @ Novena Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Life Source Medical Centre @ Novena Medical Center
Singapore, Singapore, Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTC1000031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.